мȸ ǥ ʷ

ǥ : ȣ - 510414   62 
Enhancer of polycomb1, a novel regulator of sarcomeric muscle differentiation by modulating serum response factor
전남대학교 의과대학 약리학교실¹ 유전자 제어 의과학 연구센터² 심혈관계질환 치료재생 특성화 사업단³ 심장센터⁴
김주령¹ ,², 기해진¹ ,² ,³ 정호석¹ ,² 엄광현¹ ,² 최낙원¹, ² 신세라¹ ,² 정명호³ ,⁴ 국현¹ ,² ,³
Enhancer of polycomb1 (Epc1) is an unsual member of the polycomb group gene family that regulates transcription. We previously reported that Epc1 regulated the skeletal muscle differentiation by recruiting homeobox gene (Hod), a transcriptional modulator. Here we propose that Epc1 might modulate skeletal muscle differentiation by interaction with serum response factor (SRF). Epc1-induced transactivation of α-skeletal actin was induced by co-transfection of SRF, a transcription factor regulating muscle-specific genes by binding DNA sequence known as CArG box. The result of promoter study using point mutation in α-skeletal actin suggested that CArG box was necessary to mediate synergistic interaction of Epc1 and SRF. By chromatin immunoprecipitation (ChIP) assay, it was observed that Epc1 binds to serum response element (SRE) in α-skeletal actin promoter in vivo. In gel shift assays performed with radiolabelled probes recognizing the CArG box of the α-skeletal actin promoter, Epc1 induced supershift of SRF/SRE complex, suggesting that Epc1 forms ternary complex with SRF. We further investigated possibility that Epc1 also involved in epigenetic regulation of α-skeletal actin expression. Immunoprecipitation analysis showed the physical interaction of Epc1 and p300, a histone acetyltransferases. Moreover Epc1 physically interacted with acetylated histones H3 and H4. In ChIP assays, Epc1 was shown to be involved in histone acetylation around α-skeletal actin promoter. These results suggest that Epc1 plays an important role in sarcomeric muscle differentiation by CArG box-dependent interaction with SRF and chromatin remodeling.


[ư]


logo 학술대회일정 사전등록안내 초록등록안내 초록등록/관리 숙박 및 교통 안내 전시안내